The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...
Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...
Could NfL and GFAP redefine how clinicians track progression in MS? Dr Mark Freedman joins Dr Anne Cross to explain the ...
The endocrine system plays a crucial role in regulating physiological processes and maintaining homeostasis. While previous ...
The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.
The updated version of the Sequential Organ Failure Assessment (SOFA), the global reference system in intensive care medicine ...
Objective Lupus nephritis (LN) is a prevalent renal manifestation in patients with SLE, with kidney biopsy remaining the gold ...
SMA expert Brian Lin, PhD, shares his thoughts on aging with SMA, treatment, advocacy, and supporting patients across their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback